Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines

The present study assessed plasma IgG in patients with metastatic recurrent breast cancer (mrBC) that is reactive to various T-cell epitope peptides of prostate-related antigens (PRAs), such as prostate-specific antigen, prostate-specific membrane antigen and prostate acid phosphatase. Patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Saku, Shuko, Toh, Uhi, Takao, Yuko, Sakurai, Sayaka, Yamada, Akira, Shichijo, Shigeki, Itoh, Kyogo, Akagi, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264823/
https://www.ncbi.nlm.nih.gov/pubmed/34249152
http://dx.doi.org/10.3892/etm.2021.10337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264823/
https://www.ncbi.nlm.nih.gov/pubmed/34249152
http://dx.doi.org/10.3892/etm.2021.10337

Ejemplares similares